Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia

The Clinical Leukemia Service at Roswell Park Comprehensive Cancer Center helped lead the first clinical trial of the experimental oral drug ziftomenib in patients with acute myeloid leukemia (AML). 

Read More